Delivra Health Brands Inc. (TSX-V:DHB, OTCQB:DHBUF, FRA:3F0) has launched its LivRelief Itch Relief Cream in the Canadian market, expanding its portfolio of over-the-counter health and wellness products.
The company said the product is now available through its distributors, retail partners and e-commerce channels.
The cream is designed to provide temporary relief from itching associated with eczema, psoriasis, dermatitis and minor skin irritations, including insect bites and exposure to poison ivy, poison oak and poison sumac. Delivra Health said the formulation combines hydrocortisone, calendula and chamomile to help reduce itch, irritation and inflammation, and is hypoallergenic, fragrance-free and free from parabens, petroleum and sodium lauryl sulfate.
The launch comes as skin conditions such as eczema and psoriasis remain widespread in Canada. Delivra Health cited data from the Canadian Dermatology Association indicating that up to 17% of Canadians experience atopic dermatitis during their lifetime, while Psoriasis Canada estimates that more than one million Canadians are affected by psoriasis or psoriatic arthritis.
Delivra CEO Gord Davey wrote that the launch expands the LivRelief product line beyond its chronic pain offerings and represents a new addition to the company's innovation pipeline.
"Our Itch Relief Cream product is designed to provide Canadians with a convenient and trusted option to help manage skin irritation and discomfort, and as such, this motivated us to accelerate our launch in June 2026,” Davey said.
Dr. Joseph Gabriele, inventor of the LivRelief brand, wrote that the cream was developed to help individuals manage common dermatological conditions and improve quality of life.